| Record ID | marc_columbia/Columbia-extract-20221130-016.mrc:10103425:5028 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-016.mrc:10103425:5028?format=raw |
LEADER: 05028cam a22003974a 4500
001 7523956
005 20221201005953.0
008 090423t20102010njua bf 001 0 eng
010 $a 2009015926
020 $a9780470405093 (cloth)
020 $a0470405090 (cloth)
035 $a(OCoLC)ocn317456595
035 $a(OCoLC)317456595
035 $a(NNC)7523956
035 $a7523956
040 $aDLC$cDLC$dBTCTA$dC#P$dNNC-M$dOrLoB-B
050 00 $aR853.S7$bB35 2010
082 00 $a610.72/7$222
100 1 $aBalakrishnan, N.,$d1956-$0http://id.loc.gov/authorities/names/n86001403
245 10 $aMethods and applications of statistics in the life and health sciences /$cN. Balakrishnan.
260 $aHoboken, N.J. :$bWiley,$c[2010], ©2010.
300 $axxviii, 986 pages :$billustrations ;$c26 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aWiley series in methods and applications of statistics
504 $aIncludes bibliographical references and index.
505 00 $g1.$tAalen's Addictive Risk Model -- $g2.$tAggregation -- $g3.$tAIDS Stochastic Models -- $g4.$tAll-or-None Compliance -- $g5.$tAscertainment Sampling -- $g6.$tAssessment Bias -- $g7.$tBioavailability and Bioequivalence -- $g8.$tCancer Stochastic Models -- $g9.$tCentralized Genomic Control: A Simple Approach Correcting for Population Structures in Case-Control Association Studies -- $g10.$tChange Point Methods in Genetics -- $g11.$tClassical Biostatistics -- $g12.$tClinical Trials II -- $g13.$tCluster Randomization -- $g14.$tCohort Analysis -- $g15.$tComparisons with a Control -- $g16.$tCompeting Risks -- $g17.$tCountermatched Sampling -- $g18.$tCounting Processes -- $g19.$tCox's Proportional Hazards Model -- $g20.$tCrossover Trials -- $g21.$tDesign and Analysis for Repeated Measurements -- $g22.$tDNA Fingerprinting -- $g23.$tEpidemics -- $g24.$tEpidemiological Statistics I -- $g25.$tEpidemiological Statistics II -- $g26.$tEvent History Analysis -- $g27.$tFDA Statistical Programs: An Overview -- $g28.$tFDA Statistical Programs: Human Drugs -- $g29.$tFollow-Up -- $g30.$tFrailty Models -- $g31.$tFramingham: An Evolving Longitudinal Study -- $g32.$tGenetic Linkage -- $g33.$tGroup-Sequential Methods in Biomedical Research -- $g34.$tGroup-Sequential Tests -- $g35.$tGrouped Data in Survival Analysis -- $g36.$tImage Processing -- $g37.$tImage Restoration and Reconstruction -- $g38.$tImputation and Multiple Imputation -- $g39.$tIncomplete Data -- $g40.$tInterval Censoring -- $g41.$tInterrater Agreement -- $g42.$tKaplam-Meier Estimator I -- $g43.$tKaplan-Meier Estimator II -- $g44.$tLandmark Data -- $g45.$tLongitudinal Data Analysis -- $g46.$tMeta-Analysis -- $g47.$tMissing Data: Sensitivity Analysis -- $g48.$tMultiple Testing in Clinical Trials -- $g49.$tMutation Processes -- $g50.$tNested Case-Control Sampling -- $g51.$tObservational Studies -- $g52.$tOne- and Two-Armed Bandit Problems -- $g53.$tOphthalmology -- $g54.$tPanel Count Data -- $g55.$tPlanning and Analysis of Group-Randomized Trials -- $g56.$tPredicting Preclinical Disease Using the Mixed-Effects Regression Model -- $g57.$tPredicting Random Effects in Group-Randomized Trials -- $g58.$tProbabilistic and Statistical Models for Conception -- $g59.$tProbit Analysis -- $g60.$tProspective Studies -- $g61.$tQuality Assessment for Clinical Trials -- $g62.$tRepeated Measurements -- $g63.$tReproduction Rates -- $g64.$tRetrospective Studies -- $g65.$tSample Size Determination for Clinical Trials -- $g66.$tScan Statistics -- $g67.$tSemiparametric Analysis of Competing-Risk Data -- $g68.$tSize and Shape Analysis -- $g69.$tStability Study Designs -- $g70.$tStatistical Analysis of DNA Microarray Data -- $g71.$tStatistical Genetics -- $g72.$tStatistical Methods in Bioassay -- $g73.$tStatistical Modeling of Human Fecundity -- $g74.$tStatistical Quality of Life -- $g75.$tStatistics at CDC -- $g76.$tStatistics in Dentistry -- $g77.$tStatistics in Evolutionary Genetics -- $g78.$tStatistics in Forensic Science -- $g79.$tStatistics in Human Genetics I -- $g80.$tStatistics in Human Genetics II -- $g81.$tStatistics in Medical Diagnosis -- $g82.$tStatistics in Medicine -- $g83.$tStatistics in the Pharmaceutical Industry -- $g84.$tStatistics in Spatial Epidemiology -- $g85.$tStochastic Compartment Models -- $g86.$tSurrogate Markers -- $g87.$tSurvival Analysis.
650 0 $aMedical statistics$vHandbooks, manuals, etc.
650 0 $aMedicine$xResearch$xStatistical methods$vHandbooks, manuals, etc.
650 0 $aLife sciences$xStatistical methods$vHandbooks, manuals, etc.
650 12 $aStatistics as Topic.$0https://id.nlm.nih.gov/mesh/D013223
650 22 $aMedicine.$0https://id.nlm.nih.gov/mesh/D008511
650 22 $aBiological Science Disciplines.$0https://id.nlm.nih.gov/mesh/D001690
655 2 $aHandbook.$0https://id.nlm.nih.gov/mesh/D020479
830 0 $aWiley series in methods and applications of statistics.$0http://id.loc.gov/authorities/names/no2009194636
852 00 $boff,hsl$hR853.S7$iB35 2010